Anima Biotech is pioneering Translation Control Therapeutics, a new class of drugs that control protein translation. Our novel platform enables for the first time to visualize and specifically control the synthesis of...READ MORE
BioCubaFarma is an efficient and competitive business organization that researches, develops, produces and markets medicines, diagnostic systems, medical equipment and high technology services, baseREAD MORE
BlueBee is a leading provider of high-performance genomics solutions, enabling genomic labs to substantially reduce cost and turn-around time. The BlueBee genomics platform supports cross-functional teams of...READ MORE
Bridge is an ambitious company aiming to be revenue generating within 18 months by taking the lead project to exit, via out-licencing or trade sale, by investing in the innovative programs to treat serious inflammatorREAD MORE
We started drfocused to reclaim the tens of thousands of hours of medical time that are wasted each year through form-filling, administration, and extra paperwork.
Our team brings...READ MORE
Immatics is a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting immunotherapies for the treatment of cancer.
Our transfoREAD MORE
Immunicum is establishing a unique immuno-oncology approach through the development of allogeneic, off-the-shelf cell-based therapies. Our goal is to improve survival outcomes and quality of life by.. READ MORE
ISA Pharmaceuticals is a privately held company based in the Netherlands. It focuses on the development of rationally designed, fully synthetic immunotherapeutics for the treatment of cancer and persistent viral infect..READ MORE
Lytix Biopharma is a clinical stage pharmaceutical company developing novel cancer immunotherapies, an area within cancer therapy that is aimed at activating the patient’s immune system to fight cancer. The CompREAD MORE
Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs for the treatment of age-related disorders undergoing early, middle and late stages of drug development. Our ..READ MORE
PROTEON uses bacteriophages as the foundation for preventing and eradicating infectious diseases in animals, humans and plants.
Bacteriophages are naturally occurring... READ MORE
STORM Therapeutics is a University of Cambridge spin-out, translating the groundbreaking work of Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in...READ MORE
Sign up to event updates to hear about new speakers, promotions, conference news and networking events.